Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation

NCT ID: NCT05555459

Last Updated: 2024-05-01

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 125 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-09-28
• Study Completion Date: 2028-11-30

Brief Summary

The study in question is a post market clinical follow up (PMCF) study to evaluate the safety and performance of bioabsorbable headless compression screw Inion CompressOn in selected fracture, osteotomy and arthrodeses operations of the foot and ankle. The study recruits 125 adult patients who meet the acceptance criteria. The follow-up time for each study patient is 4 years. The study is a single center single group study which is conducted in Tampere University Hospital (TAYS) in Finland. The main focus of the study in terms of performance is to evaluate the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

Detailed Description

The study in question is a post market clinical follow-up study to evaluate the safety and performance of bioabsorbable headless compression screw Inion CompressOn in selected fracture, osteotomy and arthrodeses operations of the foot and ankle. The main focus of the study in terms of performance is to evaluate the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

The Inion CompressOn™ screws are cannulated headless compression screws made of degradable co-polymers composed of L-lactic acid and D-lactic acid. These polymers have a long history of safe medical use and they degrade in vivo by hydrolysis into alpha-hydroxy acids that are metabolised by the body. The screws retain their initial strength up to 12 weeks after implantation and gradually lose their strength thereafter. Bioabsorption takes place within two to four years. The Inion CompressOn™ products are intended for maintenance of alignment and fixation of bone fractures, comminuted fractures, osteotomies, arthrodeses or bone grafts (i.e., autografts or allografts) in the presence of appropriate additional immobilization (e.g., rigid fixation implants, cast or brace).

In the field of foot and ankle traumatology the surgical indications of this study include medial malleolar fractures, Lisfranc injuries, talus fractures, calcaneal fractures and navicular bone fractures. In the field of foot and ankle orthopaedics the surgical indications of the study include arthrodesis of the talonavicular joint, calcaneacuboideal joint, tarsometatarsal joint and first metatarsophalangeal (MTP1) joint, and osteotomies of the first metatarsal bone, second metatarsal bone (weil) and calcaneal bone.

The clinical data collection acquired from this study is a requirement of the EU Notified Body as part of the admitted CE mark certification, in cases when the device is initially approved based on the clinical data of an equivalent device. In this case, the equivalent device has been Inion FreedomScrew, which is made of the same material composition and has the same indications for use. Inion CompressOn Screw has new design features such as headless design, and threading which allows compression to the fracture line. Also new sizes are introduced.

The study recruits 125 adult patients who meet the acceptance criteria and have signed the informed consent. The follow-up time for each study patient is 4 years. Each patient has 6 follow-up time points related to the study. These time points consist of:

1. screening visit (-180-0 days before operation),

2. operation (day 0),

3. post-operative follow-up 1 (6 weeks after operation +/- 1 week),

4. post-operative follow-up 2 (3 months after operation +/- 2 weeks),

5. post-operative follow-up 3 (2 years after operation +/- 2 months)

6. post-operative follow-up 4 (4 years after operation +/- 4 months) The first 4 time points are within standard care, the last 2 time points (post-operative follow-up 3 and post-operative follow-up 4) are scheduled for study purposes only to be able to gain performance and safety data based on adequate follow-up time.

The study is a single center single group study which is conducted in Tampere University Hospital (TAYS) in Finland.

Conditions

Medial Malleolus Fracture; Lisfranc Injury; Lisfranc Fracture; Talus Fracture; Calcaneus Fracture; Navicular Fracture; Deformity, Foot; Ankle Fractures; Foot Fracture; Fractures, Bone; Fracture of Foot; Foot Deformities; Foot Injury; Feet Deformity Tarsus; Metatarsalgia; Hallux Rigidus; Hallux Valgus; Deformity of Toe; Deformity of Foot

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

CompressOn group

125 participant patients undergoing bone fixation surgical operation specified in the study description. All bone fixation surgeries are performed using Inion CompressOn screws.

Group Type: EXPERIMENTAL

Operation

Intervention Type: PROCEDURE

Bone fixation operation in foot or ankle area using bioabsorbable headless screw/s

Interventions

Operation

Bone fixation operation in foot or ankle area using bioabsorbable headless screw/s

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

1. Read the patient information bulletin on the study and signed the patient consent form

2. Adult patient (over 18-year-old)

3. Suitable and in need for surgical lower limb operation listed in the indications of this study that requires fastening of bone structures with screws (or an alternative attachment method) in the ankle or foot area, according to a statement of the investigator surgeon

4. Ability to fill in questionnaires.

5. Willingness to comply with rehabilitation instructions.

6. Availability for follow-up visits.

Exclusion Criteria

1. Active infection

2. Patient conditions including limited blood supply (e.g. patients with severe circulatory disorder of the lower limb

3. Patient conditions including insufficient quality or quantity of bone (diagnosed osteoporosis, conditions causing secondary osteoporosis e.g. diabetes, rheumatism, eating disorder)

4. Patient conditions where patient cooperation cannot be guaranteed (alcohol use, drug abuse etc.)

5. High-load bearing indications (e.g., diaphyseal fractures of long bones) unless used in conjunction with traditional rigid fixation

6. Patients with significant neuropathy

7. Pregnancy

8. Patients who refuse to participate

9. Lower limb tumor or metastasis

10. Complex Regional Pain Syndrome (CRPS) in operated foot

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Inion Oy

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Mäenpää

Role: PRINCIPAL_INVESTIGATOR

Tampere University Hospital

Locations

Tampere University Hospital

Tampere, , Finland

Site Status: RECRUITING

Countries

Finland

Central Contacts

Marika Manni, MD

Role: CONTACT

marika.manni@inion.com

+358 50 366 9994

Kati Marttinen

Role: CONTACT

kati.marttinen@inion.com

+358 40 841 6217

Facility Contacts

Heikki Mäenpää, MD

Role: primary

heikki.maenpaa@pshp.fi

+358 3 311 611

Other Identifiers

CompressOn1-2022

Identifier Type: -

Identifier Source: org_study_id